One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations.
Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.
The 7th Annual MarketsandMarkets High Potent Medicines Conference to be held on 25th -26 th May 2022. This conference would address the challenges in continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.
EHS Director, BSP Pharmaceuticals, Italy
Sales Director, FPS
Head of Global Quality Assurance Chemical APIs, , Bayer, Germany
Corporate Project Engineering, Olon Spa, Italy
Quality Assurance Manager , Natrix Sciences, Malta
Senior Validation Manager, Ecolab
Senior Principal Occupational Hygienist , SafeBridge Europe
Managing Toxicologist, SafeBridge Europe
Manager, Industrial Hygiene and Toxicology, Pharmascience, Canada
Director, Scientific Affairs, PCI Services, UK
Renaissance London Heathrow Hotel - Marriott